{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:54:32Z","timestamp":1767855272165,"version":"3.49.0"},"reference-count":75,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background: Whether gender differences exist in late-onset of Alzheimer\u2019s disease (LOAD) treated with cholinesterase inhibitors (ChEIs) is not fully understood. This study investigated demographic and pharmacological characteristics in LOAD patients to determine gender differences in LOAD patients treated with ChEIs alone and ChEIs with other medications. Methods: This 5-year retrospective data analysis included 9290 LOAD AD patients with 2949 men patients and 6341 women. Potential predictors of demographic and pharmacological characteristics associated gender differences in patients treated with and without ChEIs therapy were determined using univariate analysis, while multivariable models adjusted for demographic and pharmacological variables. Results: In the adjusted analysis, men patients with LOAD that presented with a history of alcohol use (ETOH) (OR = 1.339, 95% CI, 1.072\u20131.672, p = 0.010), treated with second generation antipsychotics (SGAs) (OR = 1.271, 95% CI, 1.003\u20131.610, p = 0.047), citalopram (OR = 5.103, 95% CI, 3.423\u20137.607, p &lt; 0.001), memantine (OR = 4.409, 95% CI, 3.704\u20135.249, p &lt; 0.001), and buspirone (OR = 2.166, 95% CI, 1.437\u20133.264, p &lt; 0.001) were more likely to receive ChEIs therapy, whereas older men were less likely to be treated with ChEIs therapy. Women who were African Americans (OR = 1.387, 95% CI, 1.168\u20131.647, p &lt; 0.001), that received memantine (OR = 3.412, 95% CI, 3.034\u20133.837, p &lt; 0.001), selective serotonin reuptake inhibitor (SSRIs) (OR = 1.143, 95% CI, 1.016\u20131.287, p = 0.026), and a history of ETOH (OR = 2.109, 95% CI, 1.724\u20132.580, p &lt; 0.001) were more likely to receive ChEIs therapy, whereas older women were less likely to receive ChEIs therapy. Conclusion: In both men and women patients, those with increasing age were less likely to be treated with ChEI therapy, while patients treated with memantine were also likely to receive ChEI therapy. Our findings highlight the importance for clinicians to optimize ChEI in LOAD to improve treatment effectiveness and eliminate gender differences in ChEI therapy.<\/jats:p>","DOI":"10.3390\/brainsci12020160","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T11:02:53Z","timestamp":1643194973000},"page":"160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"12","author":[{"given":"Melissa J.","family":"Bailey-Taylor","sequence":"first","affiliation":[{"name":"PRISMA Health Upstate, Greenville, SC 29605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Poupore","sequence":"additional","affiliation":[{"name":"University of South Carolina School of Medicine Greenville, 607 Grove Rd, Greenville, SC 29605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Theriot Roley","sequence":"additional","affiliation":[{"name":"PRISMA Health Upstate, Greenville, SC 29605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Goodwin","sequence":"additional","affiliation":[{"name":"University of South Carolina School of Medicine Greenville, 607 Grove Rd, Greenville, SC 29605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooks","family":"Mcphail","sequence":"additional","affiliation":[{"name":"University of South Carolina School of Medicine Greenville, 607 Grove Rd, Greenville, SC 29605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-5050","authenticated-orcid":false,"given":"Thomas I.","family":"Nathaniel","sequence":"additional","affiliation":[{"name":"University of South Carolina School of Medicine Greenville, 607 Grove Rd, Greenville, SC 29605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"ref_1","first-page":"710","article-title":"Gender variation in the risk factors with ischemic stroke: Bangladesh perspective","volume":"24","author":"Haque","year":"2015","journal-title":"Mymensingh Med. J. MMJ"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2020). Alzheimer\u2018s association report (2020) Alzheimer\u2019s disease facts and figures. Alzheimers Dement., 16, 391\u2013460.","DOI":"10.1002\/alz.12068"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"2018 Alzheimer\u2019s disease facts and figures","volume":"14","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer\u2019s disease facts and figures","volume":"15","author":"Gaugler","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical Epidemiology of Alzheimer\u2019s disease: Assessing sex and gender differences","volume":"6","author":"Mielke","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","article-title":"Understanding the impact of sex and gender in Alzheimer\u2019s disease: A call to action","volume":"14","author":"Nebel","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.54.2.427","article-title":"Gender differences in the treatment of behavior problems in Alzheimer\u2019s disease","volume":"54","author":"Ott","year":"2000","journal-title":"Neurology"},{"key":"ref_8","first-page":"103","article-title":"Marked gender differences in progression of mild cognitive impairment over 8 years","volume":"1","author":"Lin","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","article-title":"Gender and incidence of dementia in the Framingham Heart Study from mid-adult life","volume":"11","author":"Chene","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5498\/wjp.v6.i1.54","article-title":"Sex differences in cognitive impairment in Alzheimer\u2019s disease","volume":"6","author":"Laws","year":"2016","journal-title":"World J. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","article-title":"Epidemiology of and risk factors for psychosis of Alzheimer\u2019s disease: A review of 55 studies published from 1990 to 2003","volume":"162","author":"Ropacki","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4088\/JCP.10m06574","article-title":"Effect of second-generation antipsychotics on caregiver burden in Alzheimer\u2019s disease","volume":"73","author":"Mohamed","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.2008.07111779","article-title":"Clinical symptom responses to atypical antipsychotic medications in Alzheimer\u2019s disease: Phase 1 outcomes from the CATIE-AD effectiveness trial","volume":"165","author":"Sultzer","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ebmh.12.1.20","article-title":"Atypical antipsychotics fail to improve functioning or quality of life in people with Alzheimer\u2019s disease","volume":"12","author":"Ballard","year":"2009","journal-title":"Evid.-Based Ment. Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00221-013-3818-4","article-title":"The role of serotonin in memory: Interactions with neurotransmitters and downstream signaling","volume":"232","author":"Seyedabadi","year":"2014","journal-title":"Exp. Brain Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14656566.2018.1491966","article-title":"Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: An evidence-based treatment review","volume":"19","author":"Strawn","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1673-5374.264445","article-title":"Selective serotonin reuptake inhibitors and Alzheimer\u2019s disease","volume":"15","author":"Mdawar","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/gps.3946","article-title":"Survival in dementia and predictors of mortality: A review","volume":"28","author":"Todd","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2105\/AJPH.2014.301935","article-title":"Characterization of Dementia and Alzheimer\u2019s disease in an older population: Updated Incidence and life expectancy with and without dementia","volume":"105","author":"Tom","year":"2015","journal-title":"Am. J. Public Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.arr.2016.09.005","article-title":"Sex differences in the prevalence and incidence of mild cognitive impairment: A meta-analysis","volume":"35","author":"Au","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00401-018-1908-x","article-title":"Sex and age interact to determine clinicopathologic differences in Alzheimer\u2019s disease","volume":"136","author":"Liesinger","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jalz.2007.11.007","article-title":"The oldest old and the 90+ Study","volume":"4","author":"Kawas","year":"2008","journal-title":"Alzheimers Dement."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.48.1.132","article-title":"Very old women at highest risk of dementia and Alzheimer\u2019s disease: Incidence data from the Kungsholmen project, Stockholm","volume":"48","author":"Fratiglioni","year":"1997","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","article-title":"Early-onset familial Alzheimer\u2019s disease (EOFAD)","volume":"39","author":"Wu","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1017\/S1041610214001173","article-title":"Do patients with young onset Alzheimer\u2019s disease deteriorate faster than those with late onset Alzheimer\u2019s disease? A review of the literature","volume":"26","author":"Stanley","year":"2014","journal-title":"Int. Psychogeriatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-132273","article-title":"Differences in Routine clinical practice between early and late onset Alzheimer\u2019s Disease: Data from the Swedish Dementia Registry (SveDem)","volume":"41","author":"Eriksson","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nrl.2015.08.002","article-title":"Early- and late-onset Alzheimer disease: Are they the same entity?","volume":"33","author":"Tellechea","year":"2018","journal-title":"Neurologia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2021.606600","article-title":"Effects of Alzheimer\u2019s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer\u2019s Disease","volume":"15","author":"Lee","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Birks, J. (2006). Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD005593"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11539810-000000000-00000","article-title":"Managing cognitive dysfunction through the continuum of Alzheimer\u2019s disease role of pharmacotherapy","volume":"25","author":"Delrieu","year":"2011","journal-title":"CNS Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129787","DOI":"10.1016\/j.molstruc.2020.129787","article-title":"Design, synthesis, and biological evaluation of novel indanone-based hybrids as multifunctional cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"1229","author":"Hemmati","year":"2021","journal-title":"J. Mol. Struct."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/cbdd.13825","article-title":"Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database","volume":"97","author":"Miles","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/acschemneuro.0c00627","article-title":"Recent advances in virtual screening for cholinesterase inhibitors","volume":"12","author":"Miles","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1573406415666191206095032","article-title":"Anti-Cholinesterase activity of chalcone derivatives: Synthesis, in vitro assay and molecular docking study","volume":"17","author":"Riswanto","year":"2021","journal-title":"Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000455943","article-title":"Early- versus Late-Onset Alzheimer disease: Long-Term functional outcomes, nursing home placement, and risk factors for rate of progression","volume":"7","author":"Wattmo","year":"2017","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt85","article-title":"Predictors of long-term cognitive outcome in Alzheimer\u2019s disease","volume":"3","author":"Wattmo","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0294-2","article-title":"Early- versus late-onset Alzheimer\u2019s disease in clinical practice: Cognitive and global outcomes over 3 years","volume":"9","author":"Wattmo","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1567205013666151218145752","article-title":"Testosterone, estradiol, and sex hormone-binding globulin in Alzheimer\u2019s Disease: A meta-analysis","volume":"13","author":"Xu","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0197-4580(03)00118-0","article-title":"Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: Replicability of regional differences in volume","volume":"25","author":"Raz","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000362926","article-title":"Risk factors that affect life expectancy in Alzheimer\u2019s Disease: A 15-year follow-up","volume":"38","author":"Wattmo","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_42","unstructured":"American Psychiatric Association (2018). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association."},{"key":"ref_43","first-page":"1","article-title":"Preliminary study of the validity and reliability of the Chinese version of the Saint Louis University Mental Status Examination (SLUMS) in detecting cognitive impairment in patients with traumatic brain injury","volume":"34","author":"Zhang","year":"2019","journal-title":"Appl. Neuropsychol.-Adult"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-014-0173-4","article-title":"Response to cholinesterase inhibitors affects lifespan in Alzheimer\u2019s disease","volume":"14","author":"Wattmo","year":"2014","journal-title":"BMC Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10354-021-00819-9","article-title":"Genetics of Alzheimer\u2019s disease","volume":"171","author":"Konig","year":"2021","journal-title":"Wiener Med. Wochenschr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","article-title":"Survival after initial diagnosis of Alzheimer disease","volume":"140","author":"Larson","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.9740\/mhc.n204371","article-title":"Antipsychotic use in elderly patients with dementia: Efficacy and safety concerns","volume":"4","author":"Marvanova","year":"2014","journal-title":"Ment. Health Clin."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer\u2019s Disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.conb.2011.09.001","article-title":"New developments on the role of NMDA receptors in Alzheimer\u2019s disease","volume":"22","author":"Malinow","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/WNL.0b013e3181ec68b5","article-title":"Sex differences in presentation, severity, and management of stroke in a population-based study","volume":"75","author":"Lamassa","year":"2010","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0960-894X(00)80530-2","article-title":"Cholinomimetics and Alzheimer\u2019s disease","volume":"2","author":"Jean","year":"1992","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fphar.2015.00198","article-title":"Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology","volume":"6","author":"Geerts","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbr.2016.07.023","article-title":"The combination of memantine and galantamine improves cognition in rats: The synergistic role of the \u03b17 nicotinic acetylcholine and NMDA receptors","volume":"313","author":"Nikiforuk","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/alzrt153","article-title":"Simulations of symptomatic treatments for Alzheimer\u2019s disease: Computational analysis of pathology and mechanisms of drug action","volume":"4","author":"Roberts","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","article-title":"Survival time and differences between dementia with Lewy bodies and Alzheimer\u2019s disease following diagnosis: A meta-analysis of longitudinal studies","volume":"50","author":"Mueller","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.3399\/bjgp16X688813","article-title":"Impact of coronary heart disease on cognitive decline in Alzheimer\u2019s disease: A prospective longitudinal cohort study in primary care","volume":"67","author":"Bleckwenn","year":"2017","journal-title":"Br. J. Gen. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt119","article-title":"Factors that influence survival in a probable Alzheimer disease cohort","volume":"4","author":"Rountree","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjpo.bp.116.004184","article-title":"Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer\u2019s disease","volume":"3","author":"Fazal","year":"2017","journal-title":"Bjpsych. Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jalz.2014.04.512","article-title":"Survival and early recourse to care for dementia: A population based study","volume":"11","author":"Pimouguet","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.02.001","article-title":"Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?","volume":"3","author":"Gasper","year":"2002","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-021-02130-z","article-title":"The effect of comorbidities on survival in persons with Alzheimer\u2019s disease: A matched cohort study","volume":"21","author":"Rajamaki","year":"2021","journal-title":"BMC Geriatr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/1567205013666160502123607","article-title":"Neuropsychiatric disturbances in Alzheimer\u2019s disease: What have we learned from neuropathological studies?","volume":"13","author":"Vermeiren","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u2019s disease","volume":"151","author":"Simic","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-019-0269-1","article-title":"Pharmacologic management of agitation in patients with dementia","volume":"8","author":"McDermott","year":"2019","journal-title":"Curr. Geriatr. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1017\/S1041610216002441","article-title":"Buspirone for the treatment of dementia with behavioral disturbance","volume":"29","author":"Cruz","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"ref_67","first-page":"301","article-title":"Combination\/augmentation strategies for improving the treatment of depression","volume":"1","author":"Moret","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/070674370705201004","article-title":"Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease","volume":"52","author":"Herrmann","year":"2007","journal-title":"Can. J. Psychiatry-Rev. Can. de Psychiatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","article-title":"Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u2265 65 years","volume":"15","author":"Matthews","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jalz.2009.04.1234","article-title":"Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites","volume":"5","author":"Potter","year":"2009","journal-title":"Alzheimers Dement."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1377\/hlthaff.2013.1353","article-title":"Alzheimer\u2019s Disease In African Americans: Risk Factors and Challenges for the Future","volume":"33","author":"Barnes","year":"2014","journal-title":"Health Aff."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00019442-200511000-00006","article-title":"Racial differences in the progression of cognitive decline in Alzheimer disease","volume":"13","author":"Barnes","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2018.09.009","article-title":"Perspectives on ethnic and racial disparities in Alzheimer\u2019s disease and related dementias: Update and areas of immediate need","volume":"15","author":"Babulal","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Vishwas, S., Awasthi, A., Corrie, L., Singh, S.K., and Gulati, M. (2020). Multiple target-based combination therapy of galantamine, memantine and lycopene for the possible treatment of Alzheimer\u2019s disease. Med. Hypotheses, 143.","DOI":"10.1016\/j.mehy.2020.109879"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-180903","article-title":"Present Algorithms and Future Treatments for Alzheimer\u2019s Disease","volume":"67","author":"Grossberg","year":"2019","journal-title":"J. Alzheimers Dis."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/2\/160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:04Z","timestamp":1760134084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/2\/160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["brainsci12020160"],"URL":"https:\/\/doi.org\/10.3390\/brainsci12020160","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}